heafetine glp 1 Managing GLP-1 Side Effects: Our Top Tips for Success: Hopkins MD: Primary Care Practice GLP-1 Metabolic Health | The

There is a knowledge gap in screening and management strategies for osteoporosis in patients undergoing GLP-1Ra

GLP-1 receptor agonists for the treatment of obesity: Role as a promising approach

Recent evidence also suggests potential benefits in peripheral artery disease, which was studied in the STRIDE trial, and neurodegenerative disorders, such as ongoing research in Alzheimers disease (EVOKE and EVOKE+ trials)

Drugs 74 , 20972103 (2014)

Yang J, Ren J, Song J, Liu F, Wu C, Wang X, et al

Similarly, in participants aged 75 years and above, the fracture rates were 2.4% (17/703) for semaglutide and 0.6% (4/663) for placebo, respectively [80]